How does HLA-B27 confer susceptibility to inflammatory arthritis?
- 1 October 1990
- journal article
- Published by Oxford University Press (OUP) in Clinical and Experimental Immunology
- Vol. 82 (1) , 1-2
- https://doi.org/10.1111/j.1365-2249.1990.tb05394.x
Abstract
No abstract availableThis publication has 20 references indexed in Scilit:
- Epitope mapping of an HLA-B27 monoclonal antibody that also reacts with a 35-kD bacterial outer-membrane proteinClinical and Experimental Immunology, 1990
- Antibody activity in ankylosing spondylitis sera to two sites on HLA B27.1 at the MHC groove region (within sequence 65-85), and to a Klebsiella pneumoniae nitrogenase reductase peptide (within sequence 181-199).The Journal of Experimental Medicine, 1990
- Salmonella lipopolysaccharide in synovial cells from patients with reactive arthritisThe Lancet, 1990
- Guilt by association: HLA-B27 and ankylosing spondylitisImmunology Today, 1990
- Yersinia Antigens in Synovial-Fluid Cells from Patients with Reactive ArthritisNew England Journal of Medicine, 1989
- Structure of the human class I histocompatibility antigen, HLA-A2Nature, 1987
- Cytotoxic T lymphocytes against disease-associated determinant(s) in ankylosing spondylitis.The Journal of Experimental Medicine, 1986
- REITER'S DISEASE AND HL-A 27The Lancet, 1973
- High Association of an HL-A Antigen, W27, with Ankylosing SpondylitisNew England Journal of Medicine, 1973
- ANKYLOSING SPONDYLITIS AND HL-A 27The Lancet, 1973